Summary
This white paper evaluates 35% hydrogen peroxide vapour (HPV) as a solution for RNA/DNA contamination control in qPCR laboratories. Based on experimental data from three real-world laboratory environments, it explores methodology, acceptance criteria, results and practical implications. HPV demonstrated significant reductions in environmental contamination, offering a rapid, automated alternative to manual deep cleaning. However, variability in results highlights areas for further research.
Background
PCR-based diagnostics are highly sensitive, amplifying trace nucleic acids to detectable levels. While this sensitivity is essential for accurate diagnostics, it also creates vulnerability to contamination. Even minimal RNA/DNA fragments can lead to false positives, compromising forensic investigations or clinical decisions. Traditional cleaning methods can be resource-intensive and inconsistent, particularly in complex laboratory environments. HPV, widely used for aseptic pharmaceutical environments, offers a promising oxidative mechanism to degrade nucleic acids.
The rationale for this study was to determine whether HPV could effectively degrade RNA/DNA fragments to levels that help prevent amplification in PCR reactions. This approach aligns with the industry need for rapid, automated and validated decontamination processes that help minimize downtime and operational disruption.
Study Design
Three real-world qPCR laboratories with high levels of background RNA/DNA contamination were identified. The laboratories measured 54 m³, 76 m³ and 121 m³.
Thirty swabbing locations per laboratory were sampled before and after HPV exposure using the laboratories’ standard protocols. Six-log Geobacillus stearothermophilus biological indicators were used to confirm sporicidal efficacy. The targeted level of reduction in positive amplification sites was 90%. HPV cycle parameters were based on standard Bioquell Rapid Biodecontamination Service (RBDS) settings. Swabbing was performed using sterile viscose swabs across 10 cm × 10 cm areas, processed via qPCR using COVID-19 and pMA primers. Quantification was based on Cq values and standard curves to calculate RNA/DNA copy numbers.
For the FAM channel, which detects PCT amplicon, Cq ≤ 38 indicated the presence of amplicon contamination. Cq values above this threshold were considered negligible. For the HEX channel, which detects IEC amplicon, Cq ≤ 35 indicated the presence of amplicon contamination. Cq values above this threshold were considered negligible.
Results and Discussion
Laboratory Volume | FAM Reduction | HEX Reduction | Result Summary |
|---|---|---|---|
76 m³ | 92.9% | 83.3% | Met the 90% target for FAM and approached the target for HEX |
121 m³ | 45.0% | 75.0% | Showed reduction, but remained below the 90% target |
54 m³ | 87.4% | 40.0% | Approached the 90% target for FAM, with lower reduction in HEX |
Average concentration reductions ranged from 82.7% to 86.0%. Variability was observed across surface types and contamination levels, suggesting that RNA/DNA presentation and material characteristics can influence the level of amplicon reduction.
High-concentration samples showed negligible reduction, indicating limitations in HPV’s ability to degrade dense or occluded nucleic acid deposits. Cycle parameters were not optimized for nucleic acid degradation, presenting opportunities for improvement. Anomalies included persistent contamination on sinks and undersides of benches, highlighting the need for tailored cycles and further investigation into surface-material interactions.
Despite these limitations, HPV consistently reduced contamination in complex laboratory settings within a practical timeframe. The process also achieved validated six-log sporicidal kill, reinforcing its robustness for aseptic environments.
The variability in results suggests a relationship between contamination presentation and HPV efficacy. While some surfaces achieved significant decontamination, others retained measurable contamination despite similar exposure conditions. This indicates that factors such as surface porosity, airflow patterns and condensation dynamics may influence outcomes.
Operationally, HPV offers significant advantages over manual cleaning. Traditional deep cleans require full laboratory shutdowns, extensive labor and risk of equipment damage. In contrast, HPV cycles can be completed in approximately 4.5 hours with minimal disruption, helping preserve laboratory throughput and reduce contamination risk. These benefits align with regulatory expectations for contamination control and support continuous improvement initiatives in molecular diagnostics.
Practical Implications
HPV provides a scalable, automated solution for contamination control in PCR laboratories. Its compatibility with complex setups reduces the need for equipment removal, making it relevant for high-throughput environments.
However, laboratories must validate HPV cycles for nucleic acid degradation, as current parameters are typically optimized for sporicidal activity.
Recommendations
- Evaluate the implementation of HPV cycles as part of routine contamination control in PCR laboratories.
- Optimize cycle parameters for nucleic acid degradation, including hydrogen peroxide injection and dwell time.
- Investigate the role of RNA/DNA presentation and surface type in HPV efficacy.
